Because BIG PCR happens in miniaturized packages

Video

In today's scientific environment, the pressure is on to do more with less. And how do you do that? With miniaturization. Miniaturization is the key for doing more with less in the life science industry. When you miniaturize reactions, you: . minimize sample volume . lower reagent cost . boost throughput Watch a short video of Dr. Luke Linz, LGC Laboratory Operations Manager, explaining how miniaturization works!

Watch Now

Milestones in Genomics Research

Quiz

Genetics has come a long way in it's relatively short life. But, how much do you know about the history of this amazing area of research. Take this quiz to find out!

Read more

RNA sequencing with nanopore technology

Video

New: nanopore for RNA sequencing. Sequence complete RNA strands directly and in real-time. Or, cDNA ‘strand-switching’ protocol also allows full-length sequencing of cDNA, either with or without PCR amplification.

Watch Now
Molecular Mechanism That Enable Neuronal Connections to Change With Development Discovered

Molecular Mechanism That Enable Neuronal Connections to Change With Development Discovered

News

Researchers from King's College London have discovered a molecular mechanism that enables neuronal connections to change through experience, thus fuelling learning and memory formation.

Read more
 
Innate Reaction of Hematopoietic Stem Cells to Severe Infections
News

Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide, without signals from growth factors.

Read more

Cow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS Vaccine
News

The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.

Read more

CRISPR Reveals New Targets for Promising Cancer Drugs
News

Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

Read more